AG
Advocate Group’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1M | Buy |
81,302
+2,163
| +3% | +$401K | 2.7% | 4 |
|
|
2025
Q1 | $16.6M | Buy |
79,139
+1,193
| +2% | +$250K | 3.02% | 3 |
|
|
2024
Q4 | $13.9M | Buy |
77,946
+652
| +0.8% | +$116K | 2.61% | 4 |
|
|
2024
Q3 | $15.3M | Buy |
77,294
+295
| +0.4% | +$58.3K | 2.77% | 3 |
|
|
2024
Q2 | $13.2M | Sell |
76,999
-397
| -0.5% | -$68.1K | 2.66% | 4 |
|
|
2024
Q1 | $14.1M | Sell |
77,396
-816
| -1% | -$149K | 2.8% | 3 |
|
|
2023
Q4 | $12.1M | Sell |
78,212
-1,011
| -1% | -$157K | 2.6% | 3 |
|
|
2023
Q3 | $11.8M | Buy |
79,223
+908
| +1% | +$135K | 2.74% | 3 |
|
|
2023
Q2 | $10.6M | Buy |
78,315
+3,071
| +4% | +$414K | 2.32% | 7 |
|
|
2023
Q1 | $12M | Sell |
75,244
-3,007
| -4% | -$479K | 2.62% | 3 |
|
|
2022
Q4 | $12.6M | Sell |
78,251
-2,176
| -3% | -$352K | 2.72% | 4 |
|
|
2022
Q3 | $10.8M | Sell |
80,427
-3,687
| -4% | -$495K | 2.67% | 4 |
|
|
2022
Q2 | $12.9M | Buy |
+84,114
| New | +$12.9M | 3% | 4 |
|